Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

Related Articles by Review for PubMed (Select 16575741)

1.

Marked intraindividual variability in antiretroviral concentrations may limit the utility of therapeutic drug monitoring.

Nettles RE, Kieffer TL, Parsons T, Johnson J, Cofrancesco J Jr, Gallant JE, Carson KA, Siliciano RF, Flexner C.

Clin Infect Dis. 2006 Apr 15;42(8):1189-96. Epub 2006 Mar 7. Erratum in: Clin Infect Dis. 2006 Sep 1;43(5):672.

3.

Practical guidelines to interpret plasma concentrations of antiretroviral drugs.

Kappelhoff BS, Crommentuyn KM, de Maat MM, Mulder JW, Huitema AD, Beijnen JH.

Clin Pharmacokinet. 2004;43(13):845-53. Review.

PMID:
15509183
4.
5.

Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection.

Barry M, Mulcahy F, Merry C, Gibbons S, Back D.

Clin Pharmacokinet. 1999 Apr;36(4):289-304. Review.

PMID:
10320951
6.

Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view.

Clevenbergh P, Mouly S, Sellier P, Badsi E, Cervoni J, Vincent V, Trout H, Bergmann JF.

Curr HIV Res. 2004 Oct;2(4):309-21. Review.

PMID:
15544452
7.

Warfarin-antiretroviral interactions.

Liedtke MD, Rathbun RC.

Ann Pharmacother. 2009 Feb;43(2):322-8. doi: 10.1345/aph.1L497. Epub 2009 Feb 5. Review.

PMID:
19196837
8.

Protein binding in antiretroviral therapies.

Boffito M, Back DJ, Blaschke TF, Rowland M, Bertz RJ, Gerber JG, Miller V.

AIDS Res Hum Retroviruses. 2003 Sep;19(9):825-35. Review.

PMID:
14585213
9.

Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they be applied to the current situation?

Ribera E, López-Cortés LF, Soriano V, Casado JL, Mallolas J.

Enferm Infecc Microbiol Clin. 2005 Jul;23 Suppl 2:41-67. Review. English, Spanish.

PMID:
16373004
10.

Principles and practice of HIV-protease inhibitor pharmacoenhancement.

Moyle GJ, Back D.

HIV Med. 2001 Apr;2(2):105-13. Review.

PMID:
11737387
11.

Role of sequencing in therapy selection.

Keiser P.

J Acquir Immune Defic Syndr. 2002 Feb 1;29 Suppl 1:S19-27. Review.

PMID:
11832698
12.

Protease inhibitor plasma concentrations in HIV antiretroviral therapy.

Justesen US.

Dan Med Bull. 2008 Nov;55(4):165-85. Review.

PMID:
19232158
13.

Atazanavir/ritonavir: a review of its use in HIV therapy.

von Hentig N.

Drugs Today (Barc). 2008 Feb;44(2):103-32. doi: 10.1358/dot.2008.44.2.1137107. Review.

PMID:
18389089
14.

Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract.

Else LJ, Taylor S, Back DJ, Khoo SH.

Antivir Ther. 2011;16(8):1149-67. doi: 10.3851/IMP1919. Review.

PMID:
22155899
15.

Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

Roustit M, Jlaiel M, Leclercq P, Stanke-Labesque F.

Br J Clin Pharmacol. 2008 Aug;66(2):179-95. doi: 10.1111/j.1365-2125.2008.03220.x. Epub 2008 May 15. Review.

16.

Pharmacokinetics of antiretrovirals in pregnant women.

Mirochnick M, Capparelli E.

Clin Pharmacokinet. 2004;43(15):1071-87. Review.

PMID:
15568888
17.

Antiretroviral therapy in AIDS patients with tuberculosis.

Moreno S, Hernández B, Dronda F.

AIDS Rev. 2006 Jul-Sep;8(3):115-24. Review.

PMID:
17078482
18.

Pharmacological considerations in antiretroviral therapy.

Sommadossi JP.

Antivir Ther. 1998;3 Suppl 4:9-12. Review.

PMID:
10723503
19.

Managing issues related to antiretroviral therapy.

Lesho EP, Gey DC.

Am Fam Physician. 2003 Aug 15;68(4):675-86. Review.

20.

API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.

Gupta SB, Pujari SN, Joshi SR, Patel AK; AIDS Society of India Guidelines Development Committee.

J Assoc Physicians India. 2006 Jan;54:57-74. Review.

PMID:
16649742
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk